Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.43 |
| ▸ | CLK1 | P49759 | 1/20 | 0.41 |
| ▸ | HIPK2 | Q9H2X6 | 1/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.41 |
| ▸ | RAF1 | P04049 | 1/20 | 0.40 |
| ▸ | TOP1 | P11387 | 4/20 | 0.39 |
| ▸ | CAMKK2 | Q96RR4 | 3/20 | 0.39 |
| ▸ | CAMKK1 | Q8N5S9 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.37 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13376977 | 0.92 | DHODH (0.55) | DHODHADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL13458685 | 0.90 | DHODH (0.54) | DHODHADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL28716830 | 0.85 | ADORA1 (0.41) | ADORA1ADORA3ADORA2BADORA2ATOP1 | |
| SCHEMBL29559312 | 0.85 | ADORA1 (0.41) | ADORA1ADORA3ADORA2BADORA2ATOP1 | |
| SCHEMBL5456759 | 0.84 | TOP1 (0.50) | ADORA1ADORA3ADORA2ACLK4TOP1 | |
| SCHEMBL1226790 | 0.83 | TOP1 (0.53) | ADORA1ADORA3ADORA2ACLK4TOP1 | |
| SCHEMBL10295465 | 0.80 | CTSS (0.46) | DHODHADORA1ADORA3ADORA2BADORA2A | |
| SCHEMBL19768563 | 0.79 | TOP1 (0.49) | DHODHTOP1MEN1ALDH1A1KMT2A | |
| SCHEMBL22139710 | 0.79 | TOP1 (0.46) | CLK4TOP1MEN1ALDH1A1HPGD | |
| SCHEMBL16696500 | 0.79 | TOP1 (0.49) | DHODHTOP1MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070037983-A1 | Phenanthroline derivative compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-02-15 | — | — | US | disclosed |
| US-20070037983-A1 | Phenanthroline derivative compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-02-15 | — | — | US | disclosed |
| US-20070037983-A1 | Phenanthroline derivative compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037983-A1 | Phenanthroline derivative compound | POP1, PABPC1, NAP1L1 | DHODH 1869/4885ADORA1 1846/4885ADORA3 3450/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.